In Vitro Diagnostics Quality Controls Market Size, Share, and Trends 2026 to 2035

In Vitro Diagnostics Quality Controls Market (By Product & Service: Quality Control Products (Reagents, Controls), Serum/plasma-based controls, Whole blood controls, Data Management Solutions, Quality Assurance Services; By Manufacturer Type: Third-Party Controls, Original Equipment Manufacturer (OEM) Controls; By Technology: Immunoassay Diagnostics, Clinical Chemistry Testing, Molecular Diagnostics, Hematology Diagnostics, Microbiology Diagnostics, Coagulation & Hemostasis Testing; By Application: Infectious Disease Testing, Oncology Diagnostics, Cardiology Testing, Diabetes & Metabolic Disorders, Genetic & Rare Disease Testing, Other Diagnostic Applications; By End User: Hospitals, Clinical Diagnostic Laboratories, Academic & Research Institutes, Other Healthcare Facilities) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 04 Mar 2026  |  Report Code : 7971  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on In Vitro Diagnostics Quality Controls Market 

5.1. COVID-19 Landscape: In Vitro Diagnostics Quality Controls Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global In Vitro Diagnostics Quality Controls Market, By Product & Service

8.1. In Vitro Diagnostics Quality Controls Market Revenue and Volume, by Product & Service

8.1.1. Quality Control Products (Reagents, Controls) 

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Serum/plasma-based controls

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Whole blood controls

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Data Management Solutions

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Quality Assurance Services 

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global In Vitro Diagnostics Quality Controls Market, By Manufacturer Type

9.1. In Vitro Diagnostics Quality Controls Market Revenue and Volume, by Manufacturer Type

9.1.1. Third-Party Controls 

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Original Equipment Manufacturer (OEM) Controls 

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global In Vitro Diagnostics Quality Controls Market, By Technology 

10.1. In Vitro Diagnostics Quality Controls Market Revenue and Volume, by Technology

10.1.1. Immunoassay Diagnostics 

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Clinical Chemistry Testing 

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Molecular Diagnostics 

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Hematology Diagnostics 

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Microbiology Diagnostics 

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Coagulation & Hemostasis Testing 

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global In Vitro Diagnostics Quality Controls Market, By Application

11.1. In Vitro Diagnostics Quality Controls Market Revenue and Volume, by Application

11.1.1. Infectious Disease Testing 

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Oncology Diagnostics 

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Cardiology Testing 

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Diabetes & Metabolic Disorders 

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Genetic & Rare Disease Testing

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Other Diagnostic Applications 

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global In Vitro Diagnostics Quality Controls Market, By End User

12.1. In Vitro Diagnostics Quality Controls Market Revenue and Volume, by End User

12.1.1. Hospitals 

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Clinical Diagnostic Laboratories 

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Academic & Research Institutes 

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Other Healthcare Facilities 

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global In Vitro Diagnostics Quality Controls Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product & Service

13.1.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.1.3. Market Revenue and Volume Forecast, by Technology

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product & Service

13.1.6.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.1.6.3. Market Revenue and Volume Forecast, by Technology

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product & Service

13.1.7.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.1.7.3. Market Revenue and Volume Forecast, by Technology

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product & Service

13.2.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.2.3. Market Revenue and Volume Forecast, by Technology

13.2.4. Market Revenue and Volume Forecast, by Application  

13.2.5. Market Revenue and Volume Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product & Service

13.2.6.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.2.6.3. Market Revenue and Volume Forecast, by Technology

13.2.7. Market Revenue and Volume Forecast, by Application  

13.2.8. Market Revenue and Volume Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product & Service

13.2.9.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.2.9.3. Market Revenue and Volume Forecast, by Technology

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product & Service

13.2.12.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.2.12.3. Market Revenue and Volume Forecast, by Technology

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product & Service

13.2.14.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.2.14.3. Market Revenue and Volume Forecast, by Technology

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product & Service

13.3.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.3.3. Market Revenue and Volume Forecast, by Technology

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product & Service

13.3.6.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.3.6.3. Market Revenue and Volume Forecast, by Technology

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product & Service

13.3.8.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.3.8.3. Market Revenue and Volume Forecast, by Technology

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product & Service

13.3.10.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.3.10.3. Market Revenue and Volume Forecast, by Technology

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product & Service

13.3.11.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.3.11.3. Market Revenue and Volume Forecast, by Technology

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product & Service

13.4.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.4.3. Market Revenue and Volume Forecast, by Technology

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product & Service

13.4.6.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.4.6.3. Market Revenue and Volume Forecast, by Technology

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product & Service

13.4.8.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.4.8.3. Market Revenue and Volume Forecast, by Technology

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product & Service

13.4.10.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.4.10.3. Market Revenue and Volume Forecast, by Technology

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product & Service

13.4.11.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.4.11.3. Market Revenue and Volume Forecast, by Technology

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product & Service

13.5.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.5.3. Market Revenue and Volume Forecast, by Technology

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product & Service

13.5.6.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.5.6.3. Market Revenue and Volume Forecast, by Technology

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product & Service

13.5.8.2. Market Revenue and Volume Forecast, by Manufacturer Type

13.5.8.3. Market Revenue and Volume Forecast, by Technology

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Danaher

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Randox Laboratories Ltd

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Helena Laboratories Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Thermo Fisher Scientific Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. SeraCare Life Sciences Inc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. BD

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Bio-Techne

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Merck KGaA

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Bio-Techne

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Microbiologics

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The in vitro diagnostics quality controls market size is expected to increase from USD 1.41 billion in 2025 to USD 1.94 billion by 2035.

Answer : The in vitro diagnostics quality controls market is expected to grow at a compound annual growth rate (CAGR) of around 3.24% from 2026 to 2035.

Answer : The major players in the in vitro diagnostics quality controls market include Siemens Healthineers AG, Abbott, Bio-Rad Laboratories, Danaher, Randox Laboratories Ltd, Helena Laboratories Corporation, Thermo Fisher Scientific Inc, SeraCare Life Sciences Inc, BD, Merck KGaA, QIAGEN, Hologic, Inc., Bio-Techne, Fortress Diagnostics, and Microbiologics

Answer : The driving factors of the in vitro diagnostics quality controls market are increasing use of advanced diagnostic solutions in research laboratories, coupled with the rapid expansion of the microbiology sector. 

Answer : North America region will lead the global in vitro diagnostics quality controls market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client